| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0140-6736(08)60488-2 |
| P698 | PubMed publication ID | 18374843 |
| P50 | author | Dan J. Stein | Q5213742 |
| P2093 | author name string | Murray B Stein | |
| P2860 | cites work | Mini-SPIN: A brief screening assessment for generalized social anxiety disorder | Q74826607 |
| Functional impact and health utility of anxiety disorders in primary care outpatients | Q81507339 | ||
| Illicit drug use and anxiety disorders: findings from two community surveys | Q83378225 | ||
| The factor structure and screening utility of the Social Interaction Anxiety Scale | Q83974103 | ||
| Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 | ||
| Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans | Q22255501 | ||
| Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia | Q22306274 | ||
| Oxytocin increases trust in humans | Q28254266 | ||
| Social fears and social phobia in the USA: results from the National Comorbidity Survey Replication | Q28255649 | ||
| Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing | Q28294203 | ||
| Philosophy and the DSM-III | Q30361052 | ||
| Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q30977443 | ||
| Body dysmorphic disorder and social phobia: cross-sectional and prospective data | Q31016727 | ||
| Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study | Q31825606 | ||
| Pharmacotherapy for social phobia | Q33208084 | ||
| Treatment of social phobia with gabapentin: a placebo-controlled study | Q33420919 | ||
| Low dopamine D(2) receptor binding potential in social phobia | Q33891937 | ||
| Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale | Q33903235 | ||
| Prevention of childhood anxiety disorders. | Q33930572 | ||
| Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy | Q33958852 | ||
| A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder | Q33981126 | ||
| The etiology of social phobia: empirical evidence and an initial model | Q33982553 | ||
| An insular view of anxiety | Q33996911 | ||
| Panic disorder | Q33999587 | ||
| Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life | Q34005517 | ||
| Dopamine reuptake site densities in patients with social phobia | Q34064101 | ||
| Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. | Q34156694 | ||
| Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study | Q34163102 | ||
| Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism | Q34187350 | ||
| Cognitive-behavioral treatment of social phobia: new advances | Q34213714 | ||
| Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial | Q34334039 | ||
| Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia | Q48713347 | ||
| Neural correlates of genetically abnormal social cognition in Williams syndrome | Q48813102 | ||
| Increased activation of the anterior cingulate cortex during processing of disgust faces in individuals with social phobia | Q50232277 | ||
| Are we overpathologizing the socially anxious? Social phobia from a harmful dysfunction perspective. | Q50962980 | ||
| Psychiatric correlates of childhood shyness in a nationally representative sample. | Q50964906 | ||
| Social anxiety in primary care: hidden in plain view? | Q50970052 | ||
| Social phobia subtypes in the National Comorbidity Survey. | Q51097770 | ||
| Treatment of social phobia with clonazepam and placebo. | Q51138932 | ||
| Low extraversion and high neuroticism as indices of genetic and environmental risk for social phobia, agoraphobia, and animal phobia. | Q51729713 | ||
| Impact of psychiatric disorders on health-related quality of life: general population survey. | Q51905259 | ||
| Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. | Q51906249 | ||
| Epidemiology of social phobia in later life. | Q51908129 | ||
| Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. | Q51911079 | ||
| Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. | Q51929408 | ||
| Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. | Q51930117 | ||
| Self-criticism and social phobia in the US national comorbidity survey. | Q51936481 | ||
| Childhood shyness and maternal social phobia: a community study. | Q51978826 | ||
| The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. | Q52047249 | ||
| Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. | Q52048160 | ||
| A Population-Based Twin Study of the Relationship Between Neuroticism and Internalizing Disorders | Q56905763 | ||
| The Epidemiology of Social Anxiety Disorder in the United States | Q60447041 | ||
| Do empirically supported treatments generalize to private practice? A benchmark study of a cognitive-behavioural group treatment programme for social phobia | Q60703751 | ||
| Characteristics of Social Phobia Among Persons With Essential Tremor | Q61876500 | ||
| Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents | Q61948545 | ||
| Anxiety disorders in patients with Parkinson's disease | Q68705164 | ||
| Social phobia in adults with stuttering | Q70899357 | ||
| Sertraline for social phobia: a double-blind, placebo-controlled crossover study | Q72006198 | ||
| Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine | Q72561763 | ||
| Different ages of onset in varieties of phobia | Q72864818 | ||
| Antidepressants and the risk of suicidal behaviors | Q34334805 | ||
| Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia | Q34356032 | ||
| Comorbidity of anxiety disorders with anorexia and bulimia nervosa | Q34372026 | ||
| Phenelzine vs atenolol in social phobia. A placebo-controlled comparison | Q34374338 | ||
| Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder | Q34392179 | ||
| Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors? | Q34401732 | ||
| COMT polymorphisms and anxiety-related personality traits | Q34426642 | ||
| Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo | Q34436163 | ||
| Impact of generalized social anxiety disorder in managed care | Q34453673 | ||
| Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study | Q34466830 | ||
| Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome | Q34484694 | ||
| Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. | Q34500018 | ||
| Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder | Q34500698 | ||
| Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia | Q34516106 | ||
| Prevalence of social phobia and its comorbidity with psychiatric disorders in Iran | Q34544120 | ||
| Cognitive therapy versus exposure and applied relaxation in social phobia: A randomized controlled trial | Q34544867 | ||
| Social phobia symptoms: prevalence, sociodemographic correlates, and overlap with specific phobia symptoms | Q34556791 | ||
| Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study | Q34560564 | ||
| Clinical practice. Social anxiety disorder | Q34564098 | ||
| Reduced serotonin-1A receptor binding in social anxiety disorder | Q34566534 | ||
| Common Kibra alleles are associated with human memory performance | Q34575472 | ||
| Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials | Q34619977 | ||
| Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial | Q34751994 | ||
| Associations in the course of personality disorders and Axis I disorders over time | Q35743312 | ||
| Autism: a window onto the development of the social and the analytic brain | Q36201609 | ||
| Childhood social anxiety disorder: from understanding to treatment | Q36261177 | ||
| The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior | Q36555044 | ||
| Suffering in silence: why a developmental psychopathology perspective on selective mutism is needed | Q36564706 | ||
| Familial aggregation of anxiety-related quantitative traits in generalized social phobia: clues to understanding "disorder" heritability? | Q40700420 | ||
| Psychological and pharmacological treatments of social phobia: a meta-analysis | Q40704680 | ||
| Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment | Q40735804 | ||
| A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. | Q42170403 | ||
| Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of 3 placebo-controlled paroxetine trials. | Q42671280 | ||
| Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study | Q43752226 | ||
| Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study | Q43990354 | ||
| Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder | Q44101299 | ||
| Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification | Q44686496 | ||
| Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus | Q44710943 | ||
| A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder | Q44717866 | ||
| Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study | Q44943717 | ||
| Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study | Q44993152 | ||
| A polymorphism of the beta1-adrenergic receptor is associated with low extraversion | Q45019390 | ||
| Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. | Q45038014 | ||
| Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder | Q45080033 | ||
| Selective mutism and social anxiety disorder: all in the family? | Q45112423 | ||
| Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions | Q45123969 | ||
| A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder | Q45134200 | ||
| Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions | Q45209962 | ||
| Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla | Q45239070 | ||
| A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder. | Q45260570 | ||
| Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study | Q45287914 | ||
| Child anxiety in primary care: prevalent but untreated. | Q46014539 | ||
| A direct-interview family study of generalized social phobia | Q46109745 | ||
| Heritability of social anxiety-related concerns and personality characteristics: a twin study | Q46134291 | ||
| Influence of RGS2 on anxiety-related temperament, personality, and brain function | Q46145516 | ||
| Increased amygdala activation to angry and contemptuous faces in generalized social phobia | Q46219146 | ||
| Brief measures to screen for social phobia in primary care pediatrics | Q46226345 | ||
| Using five questions to screen for five common mental disorders in primary care: diagnostic accuracy of the Anxiety and Depression Detector | Q46314040 | ||
| How shy is too shy? | Q46314899 | ||
| Disability and quality of life in social phobia: epidemiologic findings | Q46390288 | ||
| The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials. | Q46544189 | ||
| A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. | Q46783008 | ||
| Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders | Q47198970 | ||
| Social anxiety in outpatients with schizophrenia: a relevant cause of disability | Q47288464 | ||
| Is "shy bladder syndrome" a subtype of social anxiety disorder? A survey of people with paruresis | Q47316449 | ||
| Psychometric properties of the Liebowitz Social Anxiety Scale | Q47605551 | ||
| Inhibited and uninhibited infants "grown up": adult amygdalar response to novelty | Q48275185 | ||
| Striatal function in generalized social phobia: a functional magnetic resonance imaging study | Q48374065 | ||
| P433 | issue | 9618 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anxiety | Q154430 |
| P304 | page(s) | 1115-1125 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Social anxiety disorder. | |
| P478 | volume | 371 |
| Q46747041 | A 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorder |
| Q35109373 | A Cross-sectional Study of Correlation of Body Image Anxiety with Social Phobia and Their Association with Depression in the Adolescents from a Rural Area of Sangli District in India |
| Q34810936 | A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits |
| Q34314638 | A contextual approach to experiential avoidance and social anxiety: evidence from an experimental interaction and daily interactions of people with social anxiety disorder |
| Q35186695 | A pilot study of gray matter volume changes associated with paroxetine treatment and response in social anxiety disorder |
| Q36698280 | A preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: a single-arm, uncontrolled trial |
| Q35126081 | A translational neuroscience approach to understanding the development of social anxiety disorder and its pathophysiology |
| Q37603752 | ASIC1a activation enhances inhibition in the basolateral amygdala and reduces anxiety. |
| Q37704732 | Aberrant amygdala-frontal cortex connectivity during perception of fearful faces and at rest in generalized social anxiety disorder |
| Q37409573 | Aberrant pulvinar effective connectivity in generalized social anxiety disorder |
| Q37704726 | Aberrant reward center response to partner reputation during a social exchange game in generalized social phobia. |
| Q90464927 | Acute Administration of Caffeine: The Effect on Motor Coordination, Higher Brain Cognitive Functions, and the Social Behavior of BLC57 Mice |
| Q93062509 | Age Moderates Link Between Training Effects and Treatment Response to Attention Bias Modification Treatment for Social Anxiety Disorder |
| Q54988920 | Altered Amygdala Resting-State Functional Connectivity and Hemispheric Asymmetry in Patients With Social Anxiety Disorder. |
| Q37683986 | Altered Topological Properties of Brain Networks in Social Anxiety Disorder: A Resting-state Functional MRI Study. |
| Q33784800 | Altered effective connectivity network of the amygdala in social anxiety disorder: a resting-state FMRI study |
| Q46578030 | Altered executive control network resting-state connectivity in social anxiety disorder |
| Q34024627 | Amygdala reactivity to faces at varying intensities of threat in generalized social phobia: an event-related functional MRI study. |
| Q34757229 | Amygdala-cingulate intrinsic connectivity is associated with degree of social inhibition |
| Q38433714 | Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder |
| Q41338681 | An Analysis of Anxiety-Related Postings on Sina Weibo |
| Q37558916 | An evolutionary perspective on the co-occurrence of social anxiety disorder and alcohol use disorder. |
| Q36784824 | Anterior cingulate cortex and insula response during indirect and direct processing of emotional faces in generalized social anxiety disorder |
| Q28276646 | Anxiety |
| Q92145474 | Approach, avoidance, and the detection of conflict in the development of behavioral inhibition |
| Q42821693 | Are There Guidelines for the Responsible Prescription of Benzodiazepines? |
| Q34287456 | Assessing the Revised Child Anxiety and Depression Scale (RCADS) in a national sample of Danish youth aged 8-16 years |
| Q50587210 | Associations between adults' recalled childhood bullying victimization, current social anxiety, coping, and self-blame: evidence for moderation and indirect effects. |
| Q40407403 | Attachment style and oxytocin receptor gene variation interact in influencing social anxiety |
| Q91669984 | Attentional Bias Modification in Virtual Reality - A VR-Based Dot-Probe Task With 2D and 3D Stimuli |
| Q36487978 | Bidirectional modulation of anxiety-related and social behaviors by amygdala projections to the medial prefrontal cortex |
| Q64062872 | Blue Notes: Using Songwriting to Improve Student Mental Health and Wellbeing. A Pilot Randomised Controlled Trial |
| Q89636589 | Brain and behavioral alterations in subjects with social anxiety dominated by empathic embarrassment |
| Q58602605 | Brain structural connectivity and neuroticism in healthy adults |
| Q58489385 | Cannabis Use and Social Anxiety in Adolescence: The Role of Facilitation Expectancies |
| Q47809946 | Cerebellar Neural Circuits Involving Executive Control Network Predict Response to Group Cognitive Behavior Therapy in Social Anxiety Disorder. |
| Q48912882 | Cerebral responses to emotional expressions and the development of social anxiety disorder: a preliminary longitudinal study. |
| Q34762433 | Changes in Positive Self-Views Mediate the Effect of Cognitive-Behavioral Therapy for Social Anxiety Disorder |
| Q29028427 | Clinical differences between early- and late-onset social anxiety disorders |
| Q36179441 | Cognitive reappraisal self-efficacy mediates the effects of individual cognitive-behavioral therapy for social anxiety disorder |
| Q64977536 | Commentary: Forgetting the best when predicting the worst: preliminary observations on neural circuit function in adolescent social anxiety. |
| Q61811797 | Commentary: Gray Matter Structural Alterations in Social Anxiety Disorder: A Voxel-Based Meta-Analysis |
| Q44947126 | Comorbid social withdrawal (hikikomori) in outpatients with social anxiety disorder: clinical characteristics and treatment response in a case series |
| Q51749309 | Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population. |
| Q64069617 | Correlation between and Attention Deficit Hyperactivity Disorder among University Students: A Self-Reported Assessment Study |
| Q36569739 | Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia |
| Q35181827 | DSM-IV and DSM-5 social anxiety disorder in the Australian community |
| Q35769021 | Diagnostic Prediction for Social Anxiety Disorder via Multivariate Pattern Analysis of the Regional Homogeneity |
| Q99243172 | Diagnostic and dimensional evaluation of implicit reward learning in social anxiety disorder and major depression |
| Q47198382 | Differential Experimental Effects of a Short Bout of Walking, Meditation, or Combination of Walking and Meditation on State Anxiety Among Young Adults |
| Q37950898 | Differentiating high-functioning autism and social phobia |
| Q45352072 | Disability profile/clinician-rated: validity for Brazilian university students with social anxiety disorder |
| Q24648385 | Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder |
| Q35760649 | Dysfunction of ventrolateral prefrontal cortex underlying social anxiety disorder: A multi-channel NIRS study |
| Q91811147 | Effect of a School-Based Anxiety Prevention Program among Primary School Children |
| Q36338448 | Effects of cognitive bias modification on social anxiety: A meta-analysis |
| Q92376639 | Effects of intranasal insulin as an enhancer of fear extinction: a randomized, double-blind, placebo-controlled experimental study |
| Q28083141 | Emerging drugs for the treatment of anxiety |
| Q57391182 | Emotion Differentiation and Emotion Regulation in High and Low Socially Anxious Individuals: An Experience-Sampling Study |
| Q30578574 | Emotion regulation in social anxiety disorder: behavioral and neural responses to three socio-emotional tasks |
| Q39336572 | Endocannabinoid Signaling in the Control of Social Behavior |
| Q47638732 | Examining Facets of Depression and Social Anxiety: The Relation among Lack of Positive Affect, Negative Cognitions, and Emotion Dysregulation |
| Q91855616 | Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study |
| Q47690192 | Extremely prematurely born adolescents self-report of anxiety symptoms, and the mothers' reports on their offspring |
| Q47963088 | Facial affect processing in social anxiety disorder with early onset: evidence of an intensity amplification bias |
| Q36858426 | Facial emotion processing in patients with social anxiety disorder and Williams-Beuren syndrome: an fMRI study |
| Q41140023 | Failure in Cognitive Suppression of Negative Affect in Adolescents with Generalized Anxiety Disorder. |
| Q35738514 | Family and friendship informal support networks and social anxiety disorder among African Americans and Black Caribbeans |
| Q33356089 | Fathers' challenging parenting behavior prevents social anxiety development in their 4-year-old children: a longitudinal observational study |
| Q37195462 | Fear of Negative Evaluation Moderates the Effect of Subliminal Fear Priming on Rejection of Unfair Offers in the Ultimatum Game |
| Q36540463 | Functional magnetic resonance imaging during emotion recognition in social anxiety disorder: an activation likelihood meta-analysis |
| Q37352337 | Functional neuroimaging of mentalizing during the trust game in social anxiety disorder |
| Q34247138 | Functioning and disability levels in primary care out-patients with one or more anxiety disorders. |
| Q37719037 | Gender Differences in the Difficulty in Disengaging from Threat among Children and Adolescents With Social Anxiety |
| Q44319951 | Generalized joint hypermobility in professional dancers: a sign of talent or vulnerability? |
| Q38539809 | Generalized social anxiety disorder: A still-neglected anxiety disorder 3 decades since Liebowitz's review |
| Q33565134 | Genetic contributions of the serotonin transporter to social learning of fear and economic decision making |
| Q39303774 | Genetic risk variants for social anxiety |
| Q36197287 | Glucocorticoid Induces Incoordination between Glutamatergic and GABAergic Neurons in the Amygdala |
| Q36050890 | Group cognitive behavioral therapy modulates the resting-state functional connectivity of amygdala-related network in patients with generalized social anxiety disorder |
| Q50552443 | Hemispheric Asymmetries in Striatal Reward Responses Relate to Approach-Avoidance Learning and Encoding of Positive-Negative Prediction Errors in Dopaminergic Midbrain Regions. |
| Q33602367 | How embarrassing! The behavioral and neural correlates of processing social norm violations |
| Q91742834 | Imaging the socially-anxious brain: recent advances and future prospects |
| Q34077652 | Impact of cognitive behavioral therapy for social anxiety disorder on the neural dynamics of cognitive reappraisal of negative self-beliefs: randomized clinical trial |
| Q27324632 | Impact of cognitive-behavioral therapy for social anxiety disorder on the neural bases of emotional reactivity to and regulation of social evaluation. |
| Q90627926 | Impaired neural habituation to neutral faces in families genetically enriched for social anxiety disorder |
| Q50791234 | Improving outcomes in social anxiety disorder. |
| Q46030340 | Increased cortical thickness in a frontoparietal network in social anxiety disorder. |
| Q37705725 | Influence of RGS2 on sertraline treatment for social anxiety disorder |
| Q40009068 | Influence of the fusiform gyrus on amygdala response to emotional faces in the non-clinical range of social anxiety |
| Q35233274 | Integrating psychoeducation in a basic computer skills course for people suffering from social anxiety: participants' experiences |
| Q27330298 | Intensified neuronal investment in the processing of chemosensory anxiety signals in non-socially anxious and socially anxious individuals |
| Q60635367 | Internet-Based Cognitive Behavior Therapy for Social Anxiety Disorder |
| Q36002653 | Interpretation training in individuals with generalized social anxiety disorder: a randomized controlled trial |
| Q30538084 | Is there less to social anxiety than meets the eye? Behavioral and neural responses to three socio-emotional tasks |
| Q48514503 | Late-onset social anxiety disorder following traumatic brain injury |
| Q40602234 | Latent class analysis of the feared situations of social anxiety disorder: A population-based study |
| Q36315637 | Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN) |
| Q93340622 | Learning to see the threat: temporal dynamics of ERPs of motivated attention in fear conditioning |
| Q39977066 | Lifestyle and social network in individuals with high level of social phobia/anxiety symptoms: a community-based study |
| Q36194143 | Linking Individual Learning Styles to Approach-Avoidance Motivational Traits and Computational Aspects of Reinforcement Learning |
| Q37138382 | Long-term administration of escitalopram in patients with social anxiety disorder in Japan |
| Q39655922 | Longitudinal and Sex Measurement Invariance of the Affective Neuroscience Personality Scales. |
| Q53425220 | MARCKSL1 Regulates Spine Formation in the Amygdala and Controls the Hypothalamic-Pituitary-Adrenal Axis and Anxiety-Like Behaviors. |
| Q28266661 | MBSR vs aerobic exercise in social anxiety: fMRI of emotion regulation of negative self-beliefs |
| Q47113383 | Mediating Effects of Global Negative Effect Expectancies on the Association between Problematic Cannabis Use and Social Anxiety |
| Q33923562 | Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder |
| Q90737999 | Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder |
| Q43792382 | Multivariate classification of social anxiety disorder using whole brain functional connectivity. |
| Q61795780 | Neural Correlates of Self-referential Processing and Their Clinical Implications in Social Anxiety Disorder |
| Q42369118 | Neural Substrate of Group Mental Health: Insights from Multi-Brain Reference Frame in Functional Neuroimaging |
| Q59805956 | Neural evidence for persistent attentional bias to threats in patients with social anxiety disorder |
| Q37456960 | Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder |
| Q26781106 | Neuroendocrine models of social anxiety disorder |
| Q37071423 | Neuroimaging studies of pediatric social anxiety: paradigms, pitfalls and a new direction for investigating the neural mechanisms |
| Q41541817 | Neuropsychological test performance in social anxiety disorder. |
| Q90569900 | Online Social anxiety Cognitive therapy for Adolescents (OSCA): protocol for a randomised controlled trial |
| Q33906973 | Optogenetic insights on the relationship between anxiety-related behaviors and social deficits |
| Q41535736 | Oxytocin and social functioning |
| Q35421263 | Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety |
| Q30832652 | Parental life events cause behavioral difference among offspring: Adult pre-gestational restraint stress reduces anxiety across generations |
| Q34243946 | Pathophysiological mechanisms underlying increased anxiety after soman exposure: reduced GABAergic inhibition in the basolateral amygdala. |
| Q34980499 | Pharmacogenetics of anxiolytic drugs. |
| Q89625832 | Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis |
| Q47593921 | Pharmacotherapy for social anxiety disorder (SAnD). |
| Q51791556 | Population-based, multi-generational family clustering study of social anxiety disorder and avoidant personality disorder. |
| Q92662037 | Positive Roles of Resveratrol in Early Development of Testicular Germ Cells against Maternal Restraint Stress in Mice |
| Q51815264 | Pre-registration dietetic students' attitudes to learning communication skills. |
| Q33599716 | Predicting cognitive behavioral therapy response in social anxiety disorder with anterior cingulate cortex and amygdala during emotion regulation |
| Q35496649 | Predictors of Symptomatic Change and Adherence in Internet-Based Cognitive Behaviour Therapy for Social Anxiety Disorder in Routine Psychiatric Care |
| Q24654915 | Preliminary evidence of white matter abnormality in the uncinate fasciculus in generalized social anxiety disorder |
| Q30448913 | Presynaptic facilitation of glutamate release in the basolateral amygdala: a mechanism for the anxiogenic and seizurogenic function of GluK1 receptors. |
| Q82638814 | Prevalence and characteristics of significant social anxiety in children aged 8-13 years: a Norwegian cross-sectional population study |
| Q93065727 | Professionally- and Self-Trained Service Dogs: Benefits and Challenges for Partners With Disabilities |
| Q47820916 | Protein kinase C is essential for kainate-induced anxiety-related behavior and glutamatergic synapse upregulation in prelimbic cortex. |
| Q37516072 | Psychiatric comorbidity and quality of life in patients with post-stroke emotional incontinence |
| Q64087119 | Psychological Interventions for the Fear of Public Speaking: A Meta-Analysis |
| Q34607807 | Public health significance of neuroticism |
| Q42293276 | Refractory social anxiety disorder. |
| Q39140515 | Regularized Latent Class Analysis with Application in Cognitive Diagnosis |
| Q82537093 | Relational treatment strategies increase social approach behaviors in patients with Generalized Social Anxiety Disorder |
| Q37334354 | Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Social Anxiety Disorder: Case Reports and a Review of the Literature. |
| Q37447426 | Resting-state theta band connectivity and graph analysis in generalized social anxiety disorder |
| Q39182365 | Reward memory relieves anxiety-related behavior through synaptic strengthening and protein kinase C in dentate gyrus |
| Q89449795 | STUDY PROTOCOL: EXPOSURE IN VIRTUAL REALITY FOR SOCIAL ANXIETY DISORDER - a randomized controlled superiority trial comparing cognitive behavioral therapy with virtual reality based exposure to cognitive behavioral therapy with in vivo exposure |
| Q37823393 | Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials |
| Q46819432 | Self-views in social anxiety disorder: The impact of CBT versus MBSR. |
| Q48729099 | Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder |
| Q99616988 | Shared yet dissociable neural codes across eye gaze, valence and expectation |
| Q47843310 | Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study |
| Q36918395 | Social Anxiety, Stress Type, and Conformity among Adolescents |
| Q37532929 | Social Phobia Is Associated with Delayed Onset of Chickenpox, Measles, and Mumps Infections. |
| Q46828181 | Social anxiety and negative early life events in university students |
| Q26781594 | Social anxiety disorder and the psychobiology of self-consciousness |
| Q48904040 | Social anxiety disorder as a hidden psychiatric comorbidity among cancer patients |
| Q43615960 | Social anxiety disorder diagnostic criteria perform equally across age, comorbid diagnosis, and performance/interaction subtypes |
| Q41695025 | Social anxiety disorder exhibit impaired networks involved in self and theory of mind processing |
| Q31103960 | Social anxiety disorder: a critical overview of neurocognitive research |
| Q47561743 | Social anxiety disorder: looking back and moving forward |
| Q37689656 | Social anxiety disorder: questions and answers for the DSM-V. |
| Q51610861 | Social anxiety in medical students: Implications for communication skills teaching. |
| Q35679900 | Social anxiety in online and real-life interaction and their associated factors |
| Q90202489 | Social anxiety symptoms moderate the link between obesity and metabolic function |
| Q90546326 | Social approach and social vigilance are differentially regulated by oxytocin receptors in the nucleus accumbens |
| Q35295530 | Social conditioning and extinction paradigm: a translational study in virtual reality. |
| Q43439058 | Social instability stress in adolescence increases anxiety and reduces social interactions in adulthood in male Long-Evans rats |
| Q59137743 | Socially Anxious Tendencies Affect Impressions of Others' Positive and Negative Emotional Gazes |
| Q47637890 | Spanish Validation of the School Anxiety Scale-Teacher Report (SAS-TR). |
| Q47986473 | Stranger Fear and Early Risk for Social Anxiety in Preschoolers with Fragile X Syndrome Contrasted to Autism Spectrum Disorder |
| Q36649764 | Strategy for treating selective serotonin reuptake inhibitor-resistant social anxiety disorder in the clinical setting: a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment |
| Q57150226 | Subcortical brain volumes, cortical thickness and cortical surface area in families genetically enriched for social anxiety disorder - A multiplex multigenerational neuroimaging study |
| Q33778062 | Subtyping social anxiety disorder in developed and developing countries |
| Q39573343 | The Effects of Waiting for Treatment: A Meta-Analysis of Waitlist Control Groups in Randomized Controlled Trials for Social Anxiety Disorder |
| Q52559777 | The Leiden Family Lab study on Social Anxiety Disorder: A multiplex, multigenerational family study on neurocognitive endophenotypes. |
| Q47624983 | The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders. |
| Q47705555 | The association between adolescent cannabis use and anxiety: A parallel process analysis |
| Q47107865 | The association of Social Anxiety Disorder, Alcohol Use Disorder and reproduction: Results from four nationally representative samples of adults in the USA. |
| Q98182345 | The connection and background mechanisms of social fears and problematic social networking site use: A structural equation modeling analysis |
| Q37960829 | The development of anxiety disorders: considering the contributions of attachment and emotion regulation. |
| Q47856966 | The effect of Interaction Anxiousness Scale and Brief Social Phobia Scale for screening social anxiety disorder in college students: a study on discriminative validity |
| Q100723188 | The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study |
| Q47282845 | The fear of being laughed at as additional diagnostic criterion in social anxiety disorder and avoidant personality disorder? |
| Q60713018 | The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology |
| Q46316035 | The social hippocampus. |
| Q30436568 | They are laughing at me: cerebral mediation of cognitive biases in social anxiety |
| Q50706155 | Towards a framework for increasing help-seeking for social anxiety disorder. |
| Q33671378 | Trait self-consciousness predicts amygdala activation and its functional brain connectivity during emotional suppression: an fMRI analysis |
| Q34059998 | Trajectories of change in emotion regulation and social anxiety during cognitive-behavioral therapy for social anxiety disorder |
| Q38374912 | Trajectories of social anxiety, cognitive reappraisal, and mindfulness during an RCT of CBGT versus MBSR for social anxiety disorder. |
| Q35676588 | Treating adolescents with social anxiety disorder in schools |
| Q64115695 | Type D personality, anxiety sensitivity, social anxiety, and disability in patients with acne: a cross-sectional controlled study |
| Q52588970 | Understanding Social Anxiety Disorder in Adolescents and Improving Treatment Outcomes: Applying the Cognitive Model of Clark and Wells (1995). |
| Q37334776 | Unselfish genes? The quest to uncover genomic influences on prosocial behavior |
| Q57954779 | Voxel-based morphometry multi-center mega-analysis of brain structure in social anxiety disorder |
| Q93384015 | Young Adult Unemployment and Later Depression and Anxiety: Does Childhood Neighborhood Matter? |
| Q35637285 | fMRI Study of Social Anxiety during Social Ostracism with and without Emotional Support |
| Q36329100 | mGluR₁,5 activation improves network asynchrony and GABAergic synapse attenuation in the amygdala: implication for anxiety-like behavior in DBA/2 mice |
Search more.